TOI The Oncology Institute
- 1.1200
- +0.0600+5.66%
- 1.1700
- +0.0500+4.46%
The Oncology Institute News
ARS: Annual Report to Security Holders
PRE 14A: Preliminary proxy statements relating to merger or acquisition
10-K/A: Annual report (Amendment)
The Oncology Institute | 8-K: Current report
The Oncology Institute | 10-K: Annual report
The Oncology Institute | 8-K: The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.
The Oncology Institute | 144: Notice of proposed sale of securities pursuant to Rule 144
The Oncology Institute | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Havencrest Healthcare Partners GP, LLC(12.04%),Havencrest Healthcare Partners, L.P.(11.93%), etc.
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director BARASCH RICHARD A
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director Hively Brad
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director Johnson Karen Marie
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director Kaushal Mohit
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director Ling Gabriel
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director McGeorge Anne
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director O'Meara Maeve
The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director Pacala Mark L
Analysis
Price Target
No Data
